Based on SEC filing data. A biotech corporation founded in 2021 and based in Tucson, Arizona, raised $3.1 million in a convertible note round at the seed stage. The company operates in the biotechnology sector.
Get notified the moment Aqualung Therapeutics Corp. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.